{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:39:58Z","timestamp":1792697998004,"version":"4.5.0"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T00:00:00Z","timestamp":1669939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Serum uric acid (UA) within appropriate levels is reported to be beneficial in patients with idiopathic short stature (ISS). This study aimed to evaluate the association between serum UA levels and height standard deviation scores (SDS) in patients with ISS during growth hormone (GH) therapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A longitudinal study (LG Growth Study) of 182 children (mean age: 7.29\u00b12.60 years) with ISS was performed. All participants were in the prepubertal stage and treated with GH, and the data within a treatment period of 30 months were analyzed. <\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In the adjusted Pearson\u2019s correlation, UA was significantly correlated with height SDS after controlling for sex, age, and body mass index (BMI) SDS (r=0.22, p=0.007). In the adjusted multiple regression analyses, the height SDS was significantly associated with UA after controlling for sex, age, and BMI SDS (\u03b2=0.168, p=0.007). Within the 30-month treatment period, the UA levels significantly increased as the height SDS increased, and the mean UA levels at baseline and 30 months after treatment were 3.90\u00b10.64 mg\/dL and 4.71\u00b10.77 mg\/dL, respectively (p=0.007). <\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>In conclusion, UA is related to height SDS, and GH treatment leads to a significant increase in UA without hyperuricemia. Elevated UA is considered a favorable outcome of GH therapy, and further studies are needed to determine its role as a monitoring tool. <\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2022.1025005","type":"journal-article","created":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T04:44:36Z","timestamp":1669956276000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Association between uric acid and height during growth hormone therapy in children with idiopathic short stature"],"prefix":"10.3389","volume":"13","author":[{"given":"Jong Seo","family":"Yoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Jun","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Byul","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Jae","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Il Tae","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.560720","article-title":"Age and gender-specific reference intervals for uric acid level in children aged 5\u201314 years in southeast zhejiang province of China: Hyperuricemia in children may need redefinition","volume":"9","author":"Dai","year":"2021","journal-title":"Front Pediatr"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/3480718","article-title":"Hyperuricemia in children and adolescents: present knowledge and future directions","volume":"2019","author":"Kubota","year":"2019","journal-title":"J Nutr Metab"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2019.08.019","article-title":"Influence of muscle mass on the serum uric acid levels in children and adolescents","volume":"30","author":"Alvim","year":"2020","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.167549","article-title":"Relationship of insulin-like growth factor 1 and bone parameters in 7\u201315 years old apparently, healthy Indian children","volume":"19","author":"Ekbote","year":"2015","journal-title":"Indian J Endocrinol Metab"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/bjp.2008.153","article-title":"Regulation of muscle mass by growth hormone and IGF-I","volume":"154","author":"Velloso","year":"2008","journal-title":"Br J Pharmacol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1038\/s41598-021-81564-2","article-title":"Association between triglyceride glucose index and peak growth hormone in children with short stature","volume":"11","author":"Zhao","year":"2021","journal-title":"Sci Rep"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41366-018-0074-5","article-title":"Temporal relationship between hyperuricemia and obesity, and its association with future risk of type 2 diabetes","volume":"42","author":"Han","year":"2018","journal-title":"Int J Obes (Lond)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.6065\/apem.2018.23.1.43","article-title":"Design of the long-term observational cohort study with recombinant human growth hormone in Korean children: LG growth study","volume":"23","author":"Chung","year":"2018","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e0216927","DOI":"10.1371\/journal.pone.0216927","article-title":"Long-term safety and effectiveness of growth hormone therapy in Korean children with growth disorders: 5-year results of LG growth study","volume":"14","author":"Rhie","year":"2019","journal-title":"PLoS One"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3345\/kjp.2018.61.5.135","article-title":"The 2017 Korean national growth charts for children and adolescents: development, improvement, and prospects","volume":"61","author":"Kim","year":"2018","journal-title":"Korean J Pediatr"},{"key":"B11","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.clinbiochem.2011.10.003","article-title":"Reference values for serum levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in Korean children and adolescents","volume":"45","author":"Hyun","year":"2012","journal-title":"Clin Biochem"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/mus.880181416","article-title":"Myogenic hyperuricemia: what can we learn from metabolic myopathies","volume":"3","author":"Mineo","year":"1995","journal-title":"Muscle Nerve Suppl"},{"key":"B13","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12887-022-03159-8","article-title":"Body composition in preschool children with short stature: a case-control study","volume":"22","author":"Ji","year":"2022","journal-title":"BMC Pediatr"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1159\/000358520","article-title":"Height, muscle, fat and bone response to growth hormone in short children with very low birth weight born appropriate for gestational age and small for gestational age","volume":"82","author":"Berndt","year":"2014","journal-title":"Horm Res Paediatr"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.82.9.4204","article-title":"Two years of growth hormone (GH) treatment increase isometric and isokinetic muscle strength in GH-deficient adults","volume":"82","author":"Johannsson","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/4563721","article-title":"Baseline body composition in prepubertal short stature children with severe and moderate growth hormone deficiency","volume":"2016","author":"Matusik","year":"2016","journal-title":"Int J Endocrinol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2016.11.012","article-title":"Muscle and skeletal health in children and adolescents with GH deficiency","volume":"30","author":"Improda","year":"2016","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.3390\/su12093639","article-title":"Comparison of postural features and muscle strength between children with idiopathic short stature and healthy peers in relation to physical exercise","volume":"12","author":"Brusa","year":"2020","journal-title":"Sustainability"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2013-3607","article-title":"Growth hormone therapy, muscle thickness, and motor development in prader-willi syndrome: an RCT","volume":"134","author":"Reus","year":"2014","journal-title":"Pediatrics"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-2600","article-title":"Muscle function improves during growth hormone therapy in short children born small for gestational age: results of a peripheral quantitative computed tomography study on body composition","volume":"93","author":"Schweizer","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B21","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1203\/00006450-199604001-00531","article-title":"Elevated uric acid levels in blood following growth hormone therapy","volume":"39","author":"Dixit","year":"1996","journal-title":"\u2020 511. Pediatr Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/4259098","article-title":"Association between insulin-like growth factor-1 and uric acid in Chinese children and adolescents with idiopathic short stature: A cross-sectional study","volume":"2018","author":"Wang","year":"2018","journal-title":"BioMed Res Int"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-3476(96)70322-0","article-title":"Abnormal serum uric acid levels in children","volume":"128","author":"Wilcox","year":"1996","journal-title":"J Pediatr"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1080\/15257770.2011.597370","article-title":"Investigation on hyperuricemia in children with obesity or various pediatric disorders","volume":"30","author":"Kubota","year":"2011","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.6065\/apem.1938156.078","article-title":"Serum uric acid in Korean children and adolescents: Reference percentiles and association with metabolic syndrome","volume":"25","author":"Cho","year":"2020","journal-title":"Ann Pediatr Endocrinol Metab"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1025005\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T04:44:38Z","timestamp":1669956278000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1025005\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,2]]},"references-count":25,"alternative-id":["10.3389\/fendo.2022.1025005"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.1025005","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,2]]},"article-number":"1025005"}}